Recent Trends in Nanocarrier-Based Drug Delivery System for Prostate Cancer
Authors:
- 6 March 2024
- journal article
- review article
- Published by Springer Nature in AAPS PharmSciTech
- Vol. 25 (3) , 1-26
Abstract
Prostate cancer remains a significant global health concern, requiring innovative approaches for improved therapeutic outcomes. In recent years, nanoparticKeywords
This publication has 192 references indexed in Scilit:
- Trends in Prices of Drugs Used to Treat Metastatic Non–Small Cell Lung Cancer in the US From 2015 to 2020JAMA Network Open, 2022
- Crosstalk between cancer and immune cells: Role of tumor‐associated macrophages in the tumor microenvironmentCancer Medicine, 2019
- Biomaterial Scaffolds as Pre‐metastatic Niche Mimics Systemically Alter the Primary Tumor and Tumor MicroenvironmentAdvanced Healthcare Materials, 2018
- Characterization of niosomes prepared with various nonionic surfactants for paclitaxel oral deliveryJournal of Pharmaceutical Sciences, 2010
- Dendrimer Chemistry2009
- Liposome encapsulation of curcumin and resveratrol in combination reduces prostate cancer incidence in PTEN knockout miceInternational Journal of Cancer, 2009
- Nanoparticulate delivery of suicide DNA to murine prostate and prostate tumorsThe Prostate, 2007
- Multidrug resistance proteins (MRPs) and implication in drug developmentDrug Development Research, 2005
- Functional expression and localization of P‐glycoprotein at the blood brain barrierMicroscopy Research and Technique, 2002
- Staging of prostate cancerSeminars in Surgical Oncology, 1994